<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Molenaar, J.C.</title>
    <link>http://repub.eur.nl/res/aut/4540/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Cost-effectiveness of neonatal surgery: First greeted with scepticism, now increasingly accepted (Article)</title>
      <link>http://repub.eur.nl/res/pub/29355/</link>
      <pubDate>2008-02-01T00:00:00Z</pubDate>
      <description>Mortality rates in neonatal surgery have dropped markedly, illustrating the enormous progress made. Yet, new questions have arisen. To mention one, health care budgets have tightened. It follows that the effects of medical interventions should be weighted against their costs. As evidence was particularly sparse, we set out to analyse cost-effectiveness of neonatal surgery. The purpose of this article is to summarise our findings and to review recent studies. Moreover, this article explains the relevance of cost-effectiveness analysis and explores how cost-effectiveness interacts with other determinants of health care priority setting. Our research revealed that treatments for two common diagnostic categories in neonatal surgery (congenital anorectal malformations and congenital diaphragmatic hernia) produce good cost-effectiveness. Other groups also published cost-effectiveness studies in the field of neonatal surgery, although their number is still small. Contemporaneously, the economic aspects of health care have captured the interest of policy makers. Importantly, this is not to say that there are no other factors playing a role in priority setting, foremost among which are ethical questions and arguments of equity. This article concludes that, according to present evidence, neonatal surgery yields good value for money and contributes to equity in health. </description>
    </item> <item>
      <title>Short term and long term health related quality of life after congenital anorectal malformations and congenital diaphragmatic hernia (Article)</title>
      <link>http://repub.eur.nl/res/pub/8520/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>AIMS: To examine short term and long term health related quality of life
      (HRQoL) of survivors of congenital anorectal malformations (ARM) and
      congenital diaphragmatic hernia (CDH), and to compare these patients'
      HRQoL with that of the general population. METHODS: HRQoL was measured in
      286 ARM patients and 111 CDH patients. All patients were administered a
      symptom checklist and a generic HRQoL measure. For the youngest children
      (aged 1-4) the TAIQOL (a preliminary version of the TAPQOL) was used, for
      the other children (aged 5-15) the TACQOL questionnaire, and for adults
      (aged &gt;16) the SF-36. RESULTS: As appeared from the symptom checklists,
      many patients remained symptomatic into adulthood. In the youngest ARM
      patients (aged 1-4 years), generic HRQoL was severely affected, but the
      older ARM patients showed better HRQoL. In the CDH patients, the influence
      of symptoms on HRQoL seemed less profound. The instruments we used
      revealed little difference between adults treated for ARM or CDH and the
      general population. CONCLUSIONS: These results show that for two neonatal
      surgical procedures, improved survival does not come at the expense of
      poor HRQoL in adults. Even though there is considerable suffering in terms
      of both morbidity and mortality in the youngest group, the ultimate
      prognosis of survivors of the two studied congenital malformations is
      favourable. This finding can be used to reassure parents of patients in
      need of neonatal surgery for one of these conditions about the prospects
      for their child.</description>
    </item> <item>
      <title>Constipation as the presenting symptom in de novo multiple endocrine neoplasia type 2B (Article)</title>
      <link>http://repub.eur.nl/res/pub/8889/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Evaluation of lung function changes before and after surfactant application during artificial ventilation in newborn rats with congenital diaphragmatic hernia (Article)</title>
      <link>http://repub.eur.nl/res/pub/38018/</link>
      <pubDate>1994-06-27T00:00:00Z</pubDate>
      <description>Patients with congenital diaphragmatic hernia (CDH) have unilateral or bilateral hypoplasia of the lungs including delayed maturation of the terminal air sacs. Because these lungs are highly susceptible to barotrauma and oxygen toxicity, even in full-term newborns, continued research into optimal ventilatory regimen is essential to improve survival rate and to prevent ongoing lung damage. Against this background, the effect of exogenous surfactant application is evaluated. In newborn rats, CDH was induced after a single dose of 2,4 dichloro-4'-nitrophenyl (Nitrofen) (400 mg/kg) on day 10 of gestation. The newborn rats were intubated immediately after hysterotomy, transferred to a heated multichambered body plethysmograph, and artificially ventilated. Inspiratory peak pressures were initially set at 17 cm H2O, with positive end-expiratory pressure at 0 cm H2O and FIO2at 1.0. The pressure was raised in steps of 5 cm H2O, from 5 to 30 cm H2O, to obtain pressure- volume diagrams at 0, 1, and 6 hours of artificial ventilation. These measurements were obtained in controls and in CDH rats with and without endotracheal installation of bovine surfactant (n = 4 to 10 in each group). Significant differences in lung volume between CDH and control rats were observed at all time-points. Surfactant application had a positive effect on lung volume, especially in control rats at t = 1 hour. No significant differences were observed between the CDH groups at t = 1 or t = 6 hours. In this animal model, the effect of artificial ventilation as well as the beneficial short-term effect of exogenous surfactant application have been evaluated. A continued positive effect on lung volume in CDH lungs could not be determined. Routine administration of exogenous surfactant in human CDH patients is not supported by these experimental results.</description>
    </item> <item>
      <title>Wie zal er ons Kindeke douwen? (Inaugural Lecture)</title>
      <link>http://repub.eur.nl/res/pub/26770/</link>
      <pubDate>1977-02-16T00:00:00Z</pubDate>
      <description>Rede, uitgesproken op
16 februari 1977 bij de aanvaarding van het
ambt van bijzonder hoogleraar in de
Kinderchirurgie aan de Erasmus Universiteit
Rotterdam vanwege de Sophia Stichting
Wetenschappelijk Onderzoek te Rotterdam.</description>
    </item>
  </channel>
</rss>